Related Experiment Video
Updated: May 2, 2026

08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
13.2K
[Cholesterol-lowering effect of the regulatory peptide Pro-Gly-Pro-Leu]
Voprosy Pitaniia
|March 20, 2014
Summary
The peptide Pro-Gly-Pro-Leu, administered intranasally, improved lipid metabolism and normalized blood cholesterol in rats fed a high-fat diet. It also restored the anticoagulation system, reducing blood clot risk.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Context:
- High-fat diets rich in saturated fatty acids can lead to hypercholesterolemia and cardiovascular issues.
- The regulatory tetrapeptide Pro-Gly-Pro-Leu's effects on lipid metabolism and coagulation were investigated.
- Rats were fed a specific high-fat diet for 15 days to induce adverse metabolic changes.
Purpose:
- To establish the anticoagulant-fibrinolytic effects of the peptide Pro-Gly-Pro-Leu.
- To evaluate the peptide's impact on lipid metabolism and blood coagulation in rats consuming a high-fat diet.
- To investigate the potential mechanisms behind the peptide's hypocholesterolemic activity.
Summary:
- Intranasal administration of Pro-Gly-Pro-Leu (200 microg/kg) over 15 days counteracted diet-induced hypercholesterolemia and weight gain in rats.
- The peptide normalized lipid profiles, reduced blood cholesterol levels, and restored the anticoagulation system.
- The study demonstrated the peptide's ability to improve endothelial function and reduce the risk of blood clots.
Impact:
- The findings suggest Pro-Gly-Pro-Leu may be a potential therapeutic agent for managing hypercholesterolemia and preventing atherosclerosis.
- The peptide's mechanism may involve interaction with blood or brain cell receptors, leading to reduced cholesterol.
- Improved rheological properties and prevention of atherosclerotic plaques highlight the peptide's cardiovascular benefits.
Related Concept Videos
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Hormonal Regulation
37.6K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
37.6K
Regulation of Nuclear Protein Sorting
2.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
GPCRs Regulate Adenylyl Cylase Activity
6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K

